These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6760808)

  • 21. Susceptibility of Plasmodium falciparum to chloroquine and mefloquine in Somalia.
    Warsame M; Lebbad M; Ali S; Wernsdorfer WH; Björkman A
    Trans R Soc Trop Med Hyg; 1988; 82(2):202-4. PubMed ID: 3055452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between the in vitro response of Plasmodium falciparum to chloroquine, quinine and mefloquine.
    Knowles G; Davidson WL; Jolley D; Alpers MP
    Trans R Soc Trop Med Hyg; 1984; 78(2):146-50. PubMed ID: 6380010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of antimalarials against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon.
    Ringwald P; Bickii J; Basco LK
    Am J Trop Med Hyg; 1996 Sep; 55(3):254-8. PubMed ID: 8842110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
    Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N
    Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of Plasmodium falciparum to five drugs: an in vitro study of isolates mainly from Thailand.
    Thaithong S; Beale GH; Chutmongkonkul M
    Trans R Soc Trop Med Hyg; 1983; 77(2):228-31. PubMed ID: 6346591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro sensitivity of Plasmodium falciparum isolates from Burma to chloroquine quinine and mefloquine.
    Lwin M; Zaw M
    Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):453-8. PubMed ID: 2937157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro response of Plasmodium falciparum to chloroquine and mefloquine in southeast Madagascar.
    Kightlinger MB; Kightlinger LK
    Arch Inst Pasteur Madagascar; 1988; 54(1):169-74. PubMed ID: 3071976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector.
    Hogh B; Gamage-Mendis A; Butcher GA; Thompson R; Begtrup K; Mendis C; Enosse SM; Dgedge M; Barreto J; Eling W; Sinden RE
    Am J Trop Med Hyg; 1998 Feb; 58(2):176-82. PubMed ID: 9502601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum.
    Le Bras J; Durand R
    Fundam Clin Pharmacol; 2003 Apr; 17(2):147-53. PubMed ID: 12667224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmodium falciparum-malaria: resistance to chloroquine, but sensitivity to mefloquine in the Gabon. A prospective in-vitro study.
    Burchard GD; Horstmann RD; Wernsdorfer WH; Dietrich M
    Tropenmed Parasitol; 1984 Mar; 35(1):1-4. PubMed ID: 6369691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High level of sensitivity to chloroquine of 72 Plasmodium falciparum isolates from southern Cameroon in January 1985.
    Brasseur P; Druilhe P; Kouamouo J; Brandicourt O; Danis M; Moyou SR
    Am J Trop Med Hyg; 1986 Jul; 35(4):711-6. PubMed ID: 3524286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and evaluation of sulfonylurea derivatives as novel antimalarials.
    León C; Rodrigues J; Gamboa de Domínguez N; Charris J; Gut J; Rosenthal PJ; Domínguez JN
    Eur J Med Chem; 2007 Jun; 42(6):735-42. PubMed ID: 17321641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent chloroquine and Fansidar resistance of Plasmodium falciparum: an imported case from Gabon.
    Burchard GD; Winkler E
    Trop Geogr Med; 1988 Jan; 40(1):68-9. PubMed ID: 3289215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmodium falciparum: mefloquine resistance produced in vitro.
    Lambros C; Notsch JD
    Bull World Health Organ; 1984; 62(3):433-8. PubMed ID: 6380785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of artesunate combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro.
    Fivelman QL; Walden JC; Smith PJ; Folb PI; Barnes KI
    Trans R Soc Trop Med Hyg; 1999; 93(4):429-32. PubMed ID: 10674097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimalarial activity of WR 243251, a Dihydroacridinedione.
    Berman J; Brown L; Miller R; Andersen SL; McGreevy P; Schuster BG; Ellis W; Ager A; Rossan R
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1753-6. PubMed ID: 7986005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue.
    Biot C; Glorian G; Maciejewski LA; Brocard JS
    J Med Chem; 1997 Nov; 40(23):3715-8. PubMed ID: 9371235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of drug susceptibility in Plasmodium falciparum in vitro and Plasmodium berghei in vivo by mixed-function oxidase inhibitors.
    Ndifor AM; Howells RE; Bray PG; Ngu JL; Ward SA
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1318-23. PubMed ID: 8328780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in antimalarial chemotherapy and drug resistance.
    Peters W
    Adv Parasitol; 1974; 12():69-114. PubMed ID: 4217563
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro assessment of sensitivity of Plasmodium falciparum to chloroquine and mefloquine in Ghana.
    Hogerzeil HV; Hogewoning AA; van Doorn JW; Wernsdorfer WH; van der Kaay HJ
    Trans R Soc Trop Med Hyg; 1985; 79(6):808-11. PubMed ID: 3914116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.